Abstract
Hypertension is associated with high mortality and morbidity that will increase if hypertension is left untreated. Treatment adherence is crucial in blood pressure control, and monitoring patient adherence is essential to the successful management of hypertension, since nonadherence is associated with poor prognosis. There are both direct and indirect methods to monitor adherence. Direct methods can be defined as assessment of treatment response or level of drug or its metabolite in blood, urine and body fluids without any intermediate or agent. Indirect methods require several instruments, such as questionnaires, reports, devices, and monitors. Certain methods may be advantageous in specific clinical and research settings. Advances in technology (new tools, devices, laboratory methods), and new approaches to reporting will not only help patients control high blood pressure but decrease hypertension-related mortality and morbidity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Papers of particular interest are highlighted as: • Of importance •• Of major importance
• Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105–87. These updated, comprehensive guidelines for the management of arterial hypertension describe when to initiate treatment to a patient with high BP.
Chisholm-Burns MA, Spivey CA. The “cost” of medication nonadherence: consequences we cannot afford to accept. J Am Pharm Assoc. 2012;52:823–6.
Irvin MR, Shimbo D, Mann DM, Reynolds K, et al. Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension. J Clin Hypertens (Greenwich). 2012;14:694–700.
Meichenbaum D, Turk DC. Faciliating treatment adherence: a practitioner’s guidebook. New York, NY: Plenum Press; 1987.
Caetano PA, Lam JM, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther. 2006;28:1411–24.
•• Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028–35. This reports extensively evaluated adherence to treatment from methods to measuring adherence to reasons of nonadherence to solutions for nonadherence.
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97. This is a basic article on definitions of and factors related to medication adherence.
Jung O, Gechter JL, Wunder C, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31:766–74.
WHO. Framework for effective tuberculosis control. WHO/TB/94.179. Geneva: World Health Organisation; 1994.
Charokopos N, Tsiros G, Foka A, et al. Modified directly observed treatment for tuberculosis versus self-administered therapy: an observational study inrural Greece. Rural Remote Heal. 2013;13:2114.
Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc (2003). 2011;51:90–4.
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–54.
Korb-Savoldelli V, Gillaizeau F, Pouchot J, et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens (Greenwich). 2012;14:429–34.
Arnet I, Walter PN, Hersberger KE. Polymedication Electronic Monitoring System (POEMS) - a new technology for measuring adherence. Front Pharmacol. 2013;4:26.
Hughes D. When drugs don't work: economic assessment of enhancing compliance with interventions supported by electronic monitoring devices. PharmacoEconomics. 2007;25:621–35.
Haberer JE, Robbins GK, Ybarra M, et al. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav. 2012;16:375–82.
• van Onzenoort HA, Verberk WJ, Kroon AA, et al. Electronic monitoring of adherence, treatment of hypertension, and blood pressure control. Am J Hypertens. 2012;25:54–9. This study showed that electronic monitoring was not associated with better long-term BP control.
•• Ayoade A, Oladipo I. Evaluation of the correlation between self-report and electronic monitoring of adherence to hypertension therapy. Blood Press. 2012;21:161–6. This article evaluates the correlation between a direct and indirect method of monitoring adherence. It must be an example for further studies on comparison between effectiveness of medication adherence measurement reports.
Doró P, Benko R, Czakó A, et al. Optimal recall period in assessing the adherence to antihypertensive therapy: a pilot study. Int J Clin Pharm. 2011;33:690–5.
Agarwal S, Lau CT. Remote health monitoring using mobile phones and Web services. Telemed J E Health. 2010;16(5):603–7.
Conflict of Interest
Serap Erdine declare that she has no conflict of interest.
Eren Arslan declare that he has no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erdine, S., Arslan, E. Monitoring Treatment Adherence in Hypertension. Curr Hypertens Rep 15, 269–272 (2013). https://doi.org/10.1007/s11906-013-0369-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11906-013-0369-9